FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2017/08/009353 [Registered on: 11/08/2017] Trial Registered Retrospectively
Last Modified On: 10/08/2017
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Follow Up Study 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Effect of eye oleation and stimulation of vital energy points in Myopia. 
Scientific Title of Study   A Comparative Clinical Study To Evaluate The Effect of Tarpana karma And Marma Therapy in Management Of Prathama Patalagata Timira w.s.r To MYOPIA  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Gunjan Sharma  
Designation  Professor 
Affiliation  Rishikul Campus, Uttarakhand Ayurved University, Haridwar 
Address  Shlakaya Department, Opd no-5 Rishikul Campus, Uttarakhand Ayurved University, Haridwar
Shlakaya Department, Opd no-5, Rishikul Campus, Uttarakhand Ayurved University, Haridwar
Hardwar
UTTARANCHAL
249401
India 
Phone  9258030654  
Fax    
Email  gunjan06sharma@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Lotika Bharti 
Designation  MD Scholar 
Affiliation  Rishikul Campus, Uttarakhand Ayurved University, Haridwar 
Address  Shlakaya Department, Rishikul Campus, Uttarakhand Ayurved University, Haridwar
Shlakaya Department,Rishikul Campus, Uttarakhand Ayurved University, Haridwar
Hardwar
UTTARANCHAL
249401
India 
Phone  9596771236  
Fax    
Email  lotikabharti@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Lotika Bharti 
Designation  MD Scholar 
Affiliation  Rishikul Campus, Uttarakhand Ayurved University, Haridwar 
Address  Shlakaya Department, Rishikul Campus, Uttarakhand Ayurved University, Haridwar
Shlakaya Department, Rishikul Campus, Uttarakhand Ayurved University, Haridwar
Hardwar
UTTARANCHAL
249401
India 
Phone  9596771236  
Fax    
Email  lotikabharti@gmail.com  
 
Source of Monetary or Material Support  
Rishikul Campus, Uttarakhand Ayurved University, Haridwar 
 
Primary Sponsor  
Name  Rishikul Campus UAU 
Address  Department of Shlakaya, Rishikul Campus, Uttarakhand Ayurved University, Haridwar 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Lotika Bharti  Rishikul campus, haridwar  Shlakaya Department,Room no-5 Rishikul Campus Uttarakhand Ayurved University, Haridwar
Hardwar
UTTARANCHAL 
9596771236

lotikabharti@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  patient having discomfort in distant vision,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Group A-Tarpana with Phalatrikadi Ghrita Group B-20 times twice a day  Group A-2 times 7 days off 7 days on (28 days) Group B-Locally on respective marma points(28 Days)  
 
Inclusion Criteria  
Age From  10.00 Year(s)
Age To  40.00 Year(s)
Gender  Both 
Details  1. The patients presenting with classical features of Prathama Patalagata Timira/simple myopia after proper screening.
2. Patients having -0.25D to -1.5D of vision
3. Snellen’s chart reading for distant vision should be equal or less than 6/24
 
 
ExclusionCriteria 
Details  1. Dwitiya ,Tritiya and Chaturtha Patalagata Timira
2. High Myopia or progressive Myopia, Congenital Myopia
3. Patients more than -1.5D of vision.
4. Refractive errors like Hypermetropia, Astigmatism and other ocular pathologies
5. Myopia with systemic diseases like T.B, Hypertension, Diabetes Mellitus
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Subjective parameter:
Cured : more than 90 % relief in signs and symptoms and no recurrence during follow up study
Marked improvement: 75% to 90 % improvement in signs and symptoms
Moderate improvement: 50% to 75% improvement in signs and symptoms.
Mild improvement: 25% improvement in signs and symptoms.
Unchanged: less than 25% reduction in signs and symptoms.
 
28 days 
 
Secondary Outcome  
Outcome  TimePoints 
Exacerbation of Signs and symptoms  1 month 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   27/12/2016 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="7"
Days="2" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  

Timira is one of the Drishtigata Rogas which is said to be a Paramdarun vyadhi, because it is a progressive disease which invades Patalas in progressive nature and ultimately ends in blindness. On the basis of clinical feature of Timira described in texts Prathama Patalagata Timira can be correlated with myopia. Myopia is a common refractive error in which one can see near objects clearly, but objects farther away are blurred. Prevalence of myopia is increasing now a day. In India its prevalence in general population is reported to be 6.9%. Treatment modalities include eyeglasses, contact lenses and refractive surgery. But there are certain precincts that give way to Ayurveda to treat this common problem. With this aim “A Comparative Clinical Study to Evaluate the Effect of Tarpana Karma and Marma Therapy in Management of Prathama Patalagata Timira w.s.r. To Myopia” was undertaken on 40 clinically diagnosed patients of Prathama Patalagata Timira/ myopia were randomly selected from O.P.D / I.P.D. of P.G Department of Shalakya Tantra, Rishikul Campus, Haridwar. 

The clinical study was done dividing the total cases into two groups of 20 each. 

In Group A- Tarpana Karma with Phalatrikadi Ghrita for 28 days in 2 sittings of 7 days with 7 days gap.

In Group B - Marma Therapy was done on 6 Marma points (Apanga, Avarta, Sthapni, Vidhura, Kshipra And Talahridya of feet) 20 times each point twice a day for 28 days. 

Results were assessed in relation to clinical signs and symptoms on the basis of grading and scoring system and data were statistically analyzed by adopting  Wilcoxon’s Signed Rank Test and Mann Whitney test U test for inter group comparison and results were evaluated in terms of probability (p). Tarpana Karma with Phalatrikadi Ghrita and Marma Therapy both showed statistically significant (p<0.05) results on subjective parameters (blurring of vision, eye strain, headache and watering). Statistically significant results were found in visual acuity and dioptric power in Group A which were insignificant in Group B; whereas both the groups showed insignificant results in axial length. None of the therapies showed any side effects. It can be concluded from the study that Tarpana Karma with Phalatrikadi Ghrita is more efficient in Prathama Patalagata Timira/ myopia.

 
Close